elearning

Register for free and gain unlimited access to our extensive elearning library
Earn CME points and track your learning activity with hundreds of hours of continuing medical education.
Bookmark and Share

Management of Oral Chemotherapy in Older Patients

This module covers the SIOG guidelines for the effective management of oral chemotherapy in older patients. The information in this module is based on the position paper by Biganzoli L et al. ’Oral single-agent chemotherapy in older patients with solid tumours: A position paper from the International Society of Geriatric Oncology.

Access the latest SIOG guidelines with our course on the management of multiple cancers in older patients.

Published April 2017.

Management of Oral Chemotherapy in Older Patients
Module
English
0 CME Points

Target audience

This module is for medical practitioners who wish to gain knowledge on the SIOG recommended guidelines for the management of prostate cancer in older patients.

Learning objectives

By the end of this module, you should be able to:

  • Understand the challenges faced with managing older cancer patients.
  • Appreciate the advantages and disadvantages of using oral over intravenous chemotherapy.
  • Know the different available oral anticancer treatments for various cancer types and the risk for non-adherence.

IT Requirements

This module requires the learner to have a good, stable internet connection and runs best on INTERNET EXPLORER 7 AND ABOVE, and MOZILLA FIREFOX on either Windows or MacOS. FLASH ADD ON is also required to run this module.

If you are viewing this module on an iPad (through a browser), please download the free Articulate Mobile Player beforehand. Other tablet devices may not be compatible - please check for Flash compatability.

If you are experiencing technical difficulties, please contact info@ecancer.org and we will get back to you as soon as possible.

Disclosure policy

ecancer and Dr Laura Biganzoli, MD, Medical Oncology Department, New Prato Hospital, Istituto Toscano Tumori, Prato, Italy have no actual or potential conflict of interest whatsoever which impinges on the making, peer reviewing and dissemination of this SIOG e-learning module which was made possible through an unrestricted educational grant from Roche.

 

Support

Production of this module was funded by the International Society of Geriatric Oncology (SIOG) and by an unrestricted grant from Roche.